GL1X · GenesisL1 explorer

Research workbench

Catalytic domain of human phosphodiesterase 4D in complex with 3,5- dimethyl-1-phenyl-1H-pyrazole-4-carboxylic acid ethyl ester

Analyse Catalytic domain of human phosphodiesterase 4D in complex with 3,5… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1Y2C
Type
protein
Length
652 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp-specific 3',5'-cyclic phosphodiesterase 4D
EC
3.1.4.17
UniProt
Q08499
Ligands
3DE, ZN, MG
Pockets
5 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 67% helix, 1% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCamp-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.17)protein32667% helix, 1% strandQ08499

Ligands and binding sites

  • 3DE · 3,5-dimethyl-1-phenyl-1H-pyrazole-4-carboxylic acid ethyl ester · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 23 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14170.720.8238MG, 3DE, EDO
24450.700.8141MG, 3DE, EDO
32410.600.8025EDO
41730.590.8220EDO
5800.350.7512empty

Interfaces

1 interface between chains.

  • A–B · 821 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 1Y2C · Catalytic Domain Of Human Phosphodiesterase 4D In Complex With… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.